|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 1.136 SEK | +18.95% |
|
+37.53% | +55.83% |
| 08-25 | Isofol Medical gets a new fair value estimate of 1.70 kronor from Redeye | FW |
| 08-25 | Isofol Medical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ISOFOL MEDICAL AB | Specialty & Advanced Pharmaceuticals | +18.95% | +37.53% | +55.83% | +62.87% | -87.24% | 36.67M |  | | |
- Stock Market
- Stocks
- ISOFOL Stock
- Charts Isofol Medical AB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
